Frequency of raised alpha-fetoprotein level among Chinese patients with hepatocellular carcinoma related to hepatitis B and C.

by Tsai, J. F., Chang, W. Y., Jeng, J. E., Ho, M. S., Lin, Z. Y., Tsai, J. H.
Published 1994

Effect of hepatitis C and B virus infection on risk of hepatocellular carcinoma: a prospective study.

by Tsai, J. F., Jeng, J. E., Ho, M. S., Chang, W. Y., Hsieh, M. Y., Lin, Z. Y., Tsai, J. H.
Published 1997

Additive effect modification of hepatitis B surface antigen and e antigen on the development of hepatocellular carcinoma.

by Tsai, J. F., Jeng, J. E., Ho, M. S., Chang, W. Y., Hsieh, M. Y., Lin, Z. Y., Tsai, J. H.
Published 1996

Clinical evaluation of serum alpha-fetoprotein and circulating immune complexes as tumour markers of hepatocellular carcinoma.

by Tsai, J. F., Jeng, J. E., Ho, M. S., Chang, W. Y., Lin, Z. Y., Tsai, J. H.
Published 1995

Magnetically induced forward scattering at visible wavelengths in silicon nanosphere oligomers

by Yan, J. H., Liu, P., Lin, Z. Y., Wang, H., Chen, H. J., Wang, C. X., Yang, G. W.
Published 2015

Elevated urinary transforming growth factor-beta1 level as a tumour marker and predictor of poor survival in cirrhotic hepatocellular carcinoma.

by Tsai, J. F., Jeng, J. E., Chuang, L. Y., Yang, M. L., Ho, M. S., Chang, W. Y., Hsieh, M. Y., Lin, Z. Y., Tsai, J. H.
Published 1997

Clinical evaluation of urinary transforming growth factor-beta1 and serum alpha-fetoprotein as tumour markers of hepatocellular carcinoma.

by Tsai, J. F., Jeng, J. E., Chuang, L. Y., Yang, M. L., Ho, M. S., Chang, W. Y., Hsieh, M. Y., Lin, Z. Y., Tsai, J. H.
Published 1997